Viewing nowHyutecs Atorvastatin Tablets 40mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

MFDS item code 201903836 · Approved 2019.06.12 · Insurance code 649104470
Improvement of hyperlipidemia and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medicine helps reduce the risk of cardiovascular diseases. In particular, it lowers the risks of myocardial infarction and stroke, and is beneficial for patients who have undergone vascular reconstruction procedures or who have chronic stable angina. It also reduces the risk of myocardial infarction and stroke in patients with type 2 diabetes who have cardiovascular risk factors. Clinically, it reduces the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, angina, and hospitalization due to congestive heart failure in patients with coronary heart disease. Additionally, this medication is used to treat hyperlipidemia, helping to lower cholesterol and LDL-cholesterol levels while raising HDL-cholesterol levels. It is also effectively used to support dietary therapy in patients with dyslipidemia or familial hypercholesterolemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dosage range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into account. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol may be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
This medication may cause muscle-related symptoms, so if you experience severe muscle pain or weakness, or significantly elevated creatine kinase levels, stop taking it immediately and consult a doctor. It can affect liver function, so it should not be used if you have liver disease or suspected liver dysfunction, and regular liver function tests should be conducted during use. This medicine should not be given to pregnant women or women who may become pregnant, nor to nursing mothers, and fertile women should use adequate contraception. When taken with certain medications, drug concentrations may increase, raising the risk of side effects, so inform your doctor or pharmacist if you are taking other medications. Elderly patients or those with impaired kidney function are at higher risk for muscular disorders, so caution is needed, and any symptoms should be reported to healthcare professionals immediately. There is no specific antidote for overdose, so treatment should be based on symptoms, monitoring liver function and muscle enzyme levels. This drug should not be used in children, especially under 10 years of age, and in children over 10, it should be administered carefully under a doctor's guidance. If you experience unusual symptoms such as muscle pain, fatigue, or fever while taking this drug, consult your doctor immediately, and discontinue use if skin rashes or allergic reactions occur. It is advisable to avoid grapefruit juice while taking this medication as it may increase drug concentrations.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.